Sofosbuvir and Ribavirin Eradication of Refractory Hepatitis E in an Immunosuppressed Kidney Transplant Recipient

Hepatology. 2019 May;69(5):2297-2299. doi: 10.1002/hep.30428. Epub 2019 Mar 8.

Authors

Mary Drinane¹, Xiao Jing Wang², Kymberly Watt²

Affiliations

¹ Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
² Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.

PMID: 30549275
DOI: 10.1002/hep.30428

No abstract available

Publication types

Case Reports

MeSH terms

Antiviral Agents / therapeutic use*
Drug Therapy, Combination
Hepatitis E / drug therapy*
Humans
Immunosuppression Therapy
Kidney Transplantation
Male
Middle Aged
Postoperative Complications / drug therapy*
Ribavirin / therapeutic use*
Sofosbuvir / therapeutic use*

Substances

Antiviral Agents
Ribavirin
Sofosbuvir